Clinical Trial Detail

NCT ID NCT02569801
Title A Study of GDC-0810 Versus Fulvestrant in Women With Advanced or Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Genentech, Inc.
Indications

estrogen-receptor positive breast cancer

Therapies

GDC-0810

Fulvestrant

Age Groups: adult

Additional content available in CKB BOOST